Combination Anti-CTLA-4 and Anti-RANKL in Metastatic Melanoma

Mark J. Smyth, Hideo Yagita, Grant A. McArthur

DOI: 10.1200/jco.2013.51.3572
Published: 2016-04-20
Container: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Open access: unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco.2013.51.3572,
  title = {Combination Anti-CTLA-4 and Anti-RANKL in Metastatic Melanoma},
  author = {Mark J. Smyth and Hideo Yagita and Grant A. McArthur},
  year = {2016},
  journal = {Journal of Clinical Oncology},
  doi = {10.1200/jco.2013.51.3572},
  url = {https://doi.org/10.1200/jco.2013.51.3572}
}

RIS

TY  - JOUR
TI  - Combination Anti-CTLA-4 and Anti-RANKL in Metastatic Melanoma
AU  - Mark J. Smyth
AU  - Hideo Yagita
AU  - Grant A. McArthur
PY  - 2016
JO  - Journal of Clinical Oncology
DO  - 10.1200/jco.2013.51.3572
UR  - https://doi.org/10.1200/jco.2013.51.3572
ER  -

APA

Smyth, M. J., Yagita, H., & McArthur, G. A. (2016). Combination Anti-CTLA-4 and Anti-RANKL in Metastatic Melanoma. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2013.51.3572

Source records

crossref · retrieved 2026-09-25T10:06:03.679Z